{
    "2021-12-31": [
        [
            {
                "time": "",
                "original_text": "粤开策略：明年1月A股有望实现开门红 重点关註三条主线投资机会",
                "features": {
                    "keywords": [
                        "开门红",
                        "A股",
                        "投资机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华东医药：公司目前未研发非奈利酮",
                "features": {
                    "keywords": [
                        "华东医药",
                        "非奈利酮",
                        "研发"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华东医药：公司目前未有安宫牛黄丸产品，亦暂无研发该品种的计划",
                "features": {
                    "keywords": [
                        "华东医药",
                        "安宫牛黄丸",
                        "研发计划"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "老字号也玩跨界，云南白药拟增资5亿元入局医美，明年将开8家门诊",
                "features": {
                    "keywords": [
                        "云南白药",
                        "医美",
                        "增资",
                        "跨界"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "进军医美！千亿中药龙头5亿增资子公司，推进医美产业链布局…这些药企也已布局，赛道前景如何？",
                "features": {
                    "keywords": [
                        "中药龙头",
                        "医美",
                        "增资",
                        "产业链"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}